In-use periods, and the ones nobody can give you
The air shot before a pen injection removes air from the cartridge and confirms flow. Skipping it can mean a materially reduced dose, and it is skipped constantly.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
The air shot before a pen injection removes air from the cartridge and confirms flow. Skipping it can mean a materially reduced dose, and it is skipped constantly.
Mass and function are different endpoints and training affects them differently. Most coverage treats them as one.
The evidence base is one secondary analysis, several small studies and a large amount of extrapolation from bariatric surgery.
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
Bacteriostatic water contains benzyl alcohol at 0.9 per cent, which inhibits microbial growth in a preserved multiple-dose presentation. It does not sterilise a contaminated…
Weight loss reduces bone mineral density at load-bearing sites. Whether that translates into fractures in this population is unmeasured.
For licensed products the in-use period is established by stability data. For a peptide reconstituted at home there is no such data, and the honest answer is that nobody…
The argument for a baseline panel is that it makes every subsequent result interpretable. The argument against frequent monitoring is that noise accumulates faster than…
The Journal has read several hundred certificates from twenty companies. We set out what the documents actually cover, and what a reader is filling in from imagination.
A substantial proportion of the abnormal results generated during rapid weight loss are consequences of the weight loss rather than findings about the person.
The evidence base is one secondary analysis, several small studies and a large amount of extrapolation from bariatric surgery.
What the renal and hepatic outcome programmes actually measured, and over what duration.
An isoaspartate rearrangement changes the molecule and not the mass. A method that confirms identity by molecular weight alone will report it as the parent compound.
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
What was withdrawn, from whom, after how long, and what was measured afterwards.
None of what this piece asks for is commercially sensitive, and all of it is already known to whoever released the batch.
A twelve-analyte panel in a perfectly healthy person has roughly even odds of producing at least one flagged result.
A worked example: one peptide, five charge states, five mass-to-charge ratios, one molecular weight.
The compendial definitions of cold, controlled cold and controlled room temperature permit specified excursions, and knowing the permitted band is the difference between an…